Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. SQI Diagnostics Inc.
  6. News
  7. Summary
    SQD   CA78466B1085

SQI DIAGNOSTICS INC.

(SQD)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

FDA Stops Emergency Use Authorization Review of SQI Diagnostics Inc. RALI-Dx IL-6 Severity Triage Test for Covid-19 Patients

07/23/2021 | 04:30pm EDT

SQI Diagnostics Inc. announced that FDA will not continue its review of SQI's submission of the RALI-Dx™ IL-6 Severity Triage Test for Emergency Use Authorization under the "Tests for Management of COVID-19 Patients" category. The agency cites a high volume of EUA requests and its prioritization of EUA reviews according to factors including the public health need for the product and shortages of critical devices during the pandemic. The FDA has encouraged SQI to submit an application under a non-EUA regulatory pathway.


ę S&P Capital IQ 2021
All news about SQI DIAGNOSTICS INC.
09/24SQI DIAGNOSTICS : Plans to Raise About $6 Million via Private Placement
MT
09/24SQI DIAGNOSTICS INC. : Announces Private Placement with Insider Participation
AQ
09/13SQI DIAGNOSTICS : Names CEO; Falls 5%
MT
09/13SQI Diagnostics Inc. Announces Chief Executive Officer Changes
CI
09/13SQI DIAGNOSTICS : Appoints Andrew Morris as Chief Executive Officer, and Grants Options
PR
08/30SQI DIAGNOSTICS INC. : Announces Grant of Stock Options
PR
08/18SQI DIAGNOSTICS : Reports Q3 2021 Net Loss of $0.7 Million
MT
08/18SQI Diagnostics Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021
CI
08/18SQI DIAGNOSTICS : Reports Third Quarter 2021 Results
PR
07/23SQI DIAGNOSTICS : Says FDA Suspends Emergency-Use Application for Its Respiratory Distress..
MT
More news
Financials
Sales 2020 1,02 M 0,81 M 0,81 M
Net income 2020 -8,57 M -6,77 M -6,77 M
Net Debt 2020 2,51 M 1,98 M 1,98 M
P/E ratio 2020 -7,94x
Yield 2020 -
Capitalization 68,9 M 54,3 M 54,4 M
EV / Sales 2019 15,2x
EV / Sales 2020 78,7x
Nbr of Employees 42
Free-Float 51,8%
Chart SQI DIAGNOSTICS INC.
Duration : Period :
SQI Diagnostics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Andrew Morris Chief Executive Officer & Director
Morlan Reddock Chief Financial Officer
Clive J. Beddoe Executive Chairman
Eric Brouwer Director & Chief Scientific Officer
Claude Ricks Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SQI DIAGNOSTICS INC.-20.83%54
THERMO FISHER SCIENTIFIC30.58%239 899
DANAHER CORPORATION46.32%231 660
INTUITIVE SURGICAL, INC.27.53%124 147
SIEMENS HEALTHINEERS AG42.12%78 408
EDWARDS LIFESCIENCES CORPORATION32.65%74 843